- Home
- IMNM vs GOODN Comparison
IMNM vs GOODN Comparison
Compare IMNM & GOODN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- GOODN
- Stock Information
- Founded
- IMNM 2006
- GOODN N/A
- Country
- IMNM United States
- GOODN United States
- Employees
- IMNM N/A
- GOODN 72
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- GOODN Real Estate
- Sector
- IMNM Health Care
- GOODN Real Estate
- Exchange
- IMNM Nasdaq
- GOODN Nasdaq
- Market Cap
- IMNM 945.8M
- GOODN N/A
- IPO Year
- IMNM 2020
- GOODN N/A
- Fundamental
- Price
- IMNM $9.70
- GOODN $22.62
- Analyst Decision
- IMNM Strong Buy
- GOODN
- Analyst Count
- IMNM 8
- GOODN 0
- Target Price
- IMNM $24.75
- GOODN N/A
- AVG Volume (30 Days)
- IMNM 1.1M
- GOODN N/A
- Earning Date
- IMNM 11-12-2025
- GOODN N/A
- Dividend Yield
- IMNM N/A
- GOODN N/A
- EPS Growth
- IMNM N/A
- GOODN N/A
- EPS
- IMNM N/A
- GOODN N/A
- Revenue
- IMNM $12,589,000.00
- GOODN N/A
- Revenue This Year
- IMNM N/A
- GOODN N/A
- Revenue Next Year
- IMNM $154.73
- GOODN N/A
- P/E Ratio
- IMNM N/A
- GOODN N/A
- Revenue Growth
- IMNM 16.74
- GOODN N/A
- 52 Week Low
- IMNM $5.15
- GOODN N/A
- 52 Week High
- IMNM $16.55
- GOODN N/A
- Technical
- Relative Strength Index (RSI)
- IMNM 50.39
- GOODN 51.32
- Support Level
- IMNM $8.93
- GOODN $22.51
- Resistance Level
- IMNM $9.63
- GOODN $22.77
- Average True Range (ATR)
- IMNM 0.74
- GOODN 0.26
- MACD
- IMNM -0.03
- GOODN 0.03
- Stochastic Oscillator
- IMNM 52.14
- GOODN 73.08
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About GOODN Gladstone Commercial Corporation
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.